Evidence map›Paper›PMID 41945226›Full record

ArticleScience China. Life sciences2026

Erratum to: Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.

Kumar Ganesan, Cong Xu, Jianming Wu, Bing Du, Qingqing Liu, Yue Sui, Cailu Song, Jinhui Zhang, Hailin Tang, Jianping Chen

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Lactylation: a novel post-translational modification for cGAS-STING pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kumar Ganesan *School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
Cong Xu *School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
Jianming WuSchool of Pharmacy, Education Ministry Key Laboratory of Medical Electrophysiology, Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Southwest Medical University, Luzhou, 646000, China.
Bing DuCollege of Food Science, South China Agricultural University, Guangzhou, 540642, China.
Qingqing LiuSchool of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
Yue SuiSchool of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
Cailu SongState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510080, China.
Jinhui ZhangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510080, China.
Hailin TangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510080, China. tanghl@sysucc.org.cn.
Jianping ChenSchool of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China. abchen@hku.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41945226

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.